Rhythmic Auditory Stimulation on Neural Activity During Finger-tapping in PD Patients

NCT ID: NCT05839821

Last Updated: 2023-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-01

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction Bradykinesia (i.e., slow movements) is one of the most prominent symptoms of Parkinson's disease (PD) and has a negative impact on quality of life. Rhythmic auditory stimulation (RAS), a widely used and promising treatment technique, has been shown to effectively improve gait speed in PD patients. However, only few studies have explored effects and neural mechanisms of RAS on upper-limb movements. The investigators will conduct two studies to investigate effects and mechanisms of RAS on upper-limb movements in PD patients. The purpose of this study is to examine real-time neural activity when patients with PD and healthy controls listen to RAS and execute finger-tapping task simultaneously.

Methods and analysis This study will recruit patients with PD and healthy controls. Electroencephalography (EEG) will be used under six conditions related to a finger-tapping task. Two-way repeated measures analysis of variance will be performed to investigate the group and condition effects on neural mechanisms.

Study significance This study will offer evidence on RAS effects and mechanisms by investigating the changes in upper-limb movements and neural mechanisms during auditory-motor entrainment. Results from this study will provide a solid foundation for further research and clinical applications of RAS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acoustic Stimulation Parkinson Disease Electroencephalography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PD patients

Patients with Parkinson's disease

noF-noRAS

Intervention Type BEHAVIORAL

resting state, that is, without finger-tapping and without listening to RAS

F-noRAS

Intervention Type BEHAVIORAL

finger-tapping without listening to RAS

noF-100RAS

Intervention Type BEHAVIORAL

listening to RAS with the 100% of the baseline tempo and without finger-tapping

F-100RAS

Intervention Type BEHAVIORAL

finger-tapping and listening to RAS with 100 % of baseline tempo

F-105RAS

Intervention Type BEHAVIORAL

finger-tapping and listening to RAS with 105 % of baseline tempo

F-110RAS

Intervention Type BEHAVIORAL

finger-tapping and listening to RAS with 110 % of baseline tempo

Healthy controls

Healthy older adults

noF-noRAS

Intervention Type BEHAVIORAL

resting state, that is, without finger-tapping and without listening to RAS

F-noRAS

Intervention Type BEHAVIORAL

finger-tapping without listening to RAS

noF-100RAS

Intervention Type BEHAVIORAL

listening to RAS with the 100% of the baseline tempo and without finger-tapping

F-100RAS

Intervention Type BEHAVIORAL

finger-tapping and listening to RAS with 100 % of baseline tempo

F-105RAS

Intervention Type BEHAVIORAL

finger-tapping and listening to RAS with 105 % of baseline tempo

F-110RAS

Intervention Type BEHAVIORAL

finger-tapping and listening to RAS with 110 % of baseline tempo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

noF-noRAS

resting state, that is, without finger-tapping and without listening to RAS

Intervention Type BEHAVIORAL

F-noRAS

finger-tapping without listening to RAS

Intervention Type BEHAVIORAL

noF-100RAS

listening to RAS with the 100% of the baseline tempo and without finger-tapping

Intervention Type BEHAVIORAL

F-100RAS

finger-tapping and listening to RAS with 100 % of baseline tempo

Intervention Type BEHAVIORAL

F-105RAS

finger-tapping and listening to RAS with 105 % of baseline tempo

Intervention Type BEHAVIORAL

F-110RAS

finger-tapping and listening to RAS with 110 % of baseline tempo

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* (a) idiopathic PD diagnosed by a neurologist based on the Movement Disorders Society clinical diagnostic criteria;
* (b) the Hoehn and Yahr stage is 2 or 3, meaning that bilateral movement problems or combination with mild postural instability;
* (c) a score of Montreal Cognitive Assessment (MoCA) is equal to or higher than 21 to ensure that they understand experimental instructions;
* (d) a score of Edinburgh Handedness Inventory is above 60 to ensure that they are right-handed;
* (e) types and doses of medications remain unchanged in the past month right before participation.
* Age- and sex-matched healthy controls who filled the criteria (c) and (d) will be recruited from communities.

Exclusion Criteria

* the presence of medical conditions or diseases that may affect hand movements, vision, or hearing based on self-report.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Hong Kong Polytechnic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

FAN Wei

PhD Candidate

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wei FAN (PhD student), MSc

Role: PRINCIPAL_INVESTIGATOR

Rehabilitation Sciences

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wei FAN (PhD student), MSc

Role: CONTACT

+85267681229

Shu-mei Wang (supervisor), PhD

Role: CONTACT

+85227664197

References

Explore related publications, articles, or registry entries linked to this study.

Fan W, Li J, Wei W, Xiao SH, Liao ZJ, Wang SM, Fong KNK. Effects of rhythmic auditory stimulation on upper-limb movements in patients with Parkinson's disease. Parkinsonism Relat Disord. 2022 Aug;101:27-30. doi: 10.1016/j.parkreldis.2022.06.020. Epub 2022 Jun 23.

Reference Type BACKGROUND
PMID: 35763906 (View on PubMed)

Wang SM, Chan ST, Wong YL, Hsu HM, Lee CY, Check CY, Leung CK. Rhythmic auditory stimulation incorporated in training improved movements in individuals with psychotic-like experiences. Eur Arch Psychiatry Clin Neurosci. 2023 Jun;273(4):995-1005. doi: 10.1007/s00406-022-01524-3. Epub 2022 Nov 24.

Reference Type BACKGROUND
PMID: 36422679 (View on PubMed)

Leuk JSP, Low LLN, Teo WP. An Overview of Acoustic-Based Interventions to Improve Motor Symptoms in Parkinson's Disease. Front Aging Neurosci. 2020 Aug 14;12:243. doi: 10.3389/fnagi.2020.00243. eCollection 2020.

Reference Type BACKGROUND
PMID: 32922283 (View on PubMed)

Thaut MH, McIntosh GC, Rice RR, Miller RA, Rathbun J, Brault JM. Rhythmic auditory stimulation in gait training for Parkinson's disease patients. Mov Disord. 1996 Mar;11(2):193-200. doi: 10.1002/mds.870110213.

Reference Type BACKGROUND
PMID: 8684391 (View on PubMed)

Koshimori Y, Thaut MH. Future perspectives on neural mechanisms underlying rhythm and music based neurorehabilitation in Parkinson's disease. Ageing Res Rev. 2018 Nov;47:133-139. doi: 10.1016/j.arr.2018.07.001. Epub 2018 Jul 10.

Reference Type BACKGROUND
PMID: 30005957 (View on PubMed)

Dong VA, Fong KN, Chen YF, Tseng SS, Wong LM. 'Remind-to-move' treatment versus constraint-induced movement therapy for children with hemiplegic cerebral palsy: a randomized controlled trial. Dev Med Child Neurol. 2017 Feb;59(2):160-167. doi: 10.1111/dmcn.13216. Epub 2016 Aug 9.

Reference Type BACKGROUND
PMID: 27503605 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HongKongPU21037721r_20230220

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NMT for Parkinson's Disease
NCT03049033 RECRUITING NA